Patent details

Basic Information

Publication number:

EP3198028

PCT Application Number:

EP2015072095

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157675307

PCT Publication Number:

WO2016046365

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A METHOD FOR PREDICTING RESPONSIVENESS TO A TREATMENT WITH AN EGFR INHIBITOR

French Title of Invention:

PROCÉDÉ DE PRÉDICTION DE LA RÉACTIVITÉ À UN TRAITEMENT AVEC UN ANTICORPS ANTI-EGFR

German Title of Invention:

VERFAHREN ZUR VORHERSAGE DER REAKTION AUF EINE BEHANDLUNG MIT EINEM EGFR-INHIBITOR

SPC Number:

Dates

Filing date:

25/09/2015

Grant date:

12/12/2018

EP Publication Date:

02/08/2017

PCT Publication Date:

31/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/12/2018

EP B1 Publication Date:

12/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/09/2019

Expiration date:

25/09/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/12/2018

 

 

Name:

Integragen

Address:

Génopole Campus 1 5, rue Henri Desbruères Génavenir 8, 91000 Evry, France (FR)

Inventor

Name:

THIEBAUT, Raphaële

Address:

France (FR)

Priority

Priority Number:

14306490

Priority Date:

26/09/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:

201850

Publication date:

12/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages